| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,723 |
1,459 |
$65K |
| 99354 |
|
635 |
584 |
$62K |
| 90480 |
|
259 |
257 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
194 |
188 |
$10K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
855 |
688 |
$8K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
44 |
44 |
$4K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
260 |
248 |
$4K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
475 |
469 |
$4K |
| 96127 |
|
349 |
347 |
$4K |
| 92552 |
|
73 |
72 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
553 |
495 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
44 |
43 |
$1K |
| 94664 |
|
51 |
42 |
$692.93 |
| 92551 |
|
177 |
176 |
$642.88 |
| 91322 |
|
38 |
38 |
$581.12 |
| H0049 |
Alcohol and/or drug screening |
14 |
14 |
$336.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
12 |
12 |
$243.60 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
171 |
160 |
$161.25 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
14 |
14 |
$119.98 |
| 86580 |
|
14 |
14 |
$108.36 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
47 |
47 |
$82.86 |
| 99173 |
|
120 |
120 |
$46.34 |
| 90686 |
|
152 |
152 |
$40.00 |
| 80061 |
Lipid panel |
74 |
73 |
$0.00 |
| 99080 |
|
124 |
124 |
$0.00 |
| 99051 |
|
53 |
49 |
$0.00 |
| 86480 |
|
15 |
15 |
$0.00 |
| 91321 |
|
95 |
95 |
$0.00 |
| 87806 |
|
14 |
14 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
13 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
12 |
12 |
$0.00 |
| 99172 |
|
177 |
176 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
14 |
14 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
76 |
75 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
30 |
30 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12 |
12 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
74 |
73 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
76 |
75 |
$0.00 |
| 81005 |
|
84 |
82 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
169 |
168 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
74 |
74 |
$0.00 |
| 87070 |
|
15 |
13 |
$0.00 |
| 90656 |
|
185 |
185 |
$0.00 |
| G9275 |
Documentation that patient is a current non-tobacco user |
15 |
15 |
$0.00 |
| 99406 |
|
14 |
14 |
$0.00 |
| 86592 |
|
14 |
14 |
$0.00 |
| 1000F |
|
15 |
15 |
$0.00 |
| 1036F |
|
15 |
15 |
$0.00 |
| 84479 |
|
19 |
19 |
$0.00 |